Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.
Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.
Address: Top Floor, 111 Rathmines Road Lr, Dublin 6
Tel: 353 (01) 441 0024
GreenCross Publishing is owned by Graham Cooke.
You are reading 1 of 2 free-access articles allowed for 30 days
Detention figures for illegally supplied HIV pre-exposure prophylaxis (PrEP) upon entry to Ireland have exceeded 2018’s figures in the first quarter of this year alone.
Throughout all of 2018, there were seven separate detentions of PrEP tablets upon entry into Ireland. These detentions comprised of 660 tablets, according to figures released to the Medical Independent (MI) by the Health Products Regulatory Authority (HPRA). A spokesperson for the HPRA told MI that the tablets detained were found to be tenofovir disoproxil, and the generic products Tenvir-EM (tenofovir and emtricitabine), manufactured by Cipla, and Ricovir-EM (tenofovir and emtricitabine), manufactured by Mylan.
The first quarter of this year alone has seen more PrEP tablets detained than throughout all of 2018. Between January 1 and March 31, some 840 PrEP tablets were detained upon entry into Ireland, spanning nine separate detentions, according to the HPRA. The tablets were identified by the HPRA as tenofovir disoproxil, tenofovir and emtricitabine and Tenvir-EM.
The spokesperson said that when recording a detention of illegally supplied medication, “while the active ingredient(s) in a product are recorded in all instances, it can be the case that, on occasion, the actual brand name is not”.
They added there was no obvious explanation for the variance between the 2018 and 2019 figures.
PrEP is currently available in Ireland legally with a doctor’s prescription. A month’s supply of branded Truvada tablets costs around €400.
As of December 2017, generic versions are available in Ireland which cost around €85-€100 per month. This is not covered by the Drugs Payment Scheme and must be paid in full by those purchasing the medication. More affordable versions of generic PrEP tablets can be bought online, but obtaining prescription medicine without a prescription is a criminal offence in Ireland.
Minister for Health Simon Harris has said that a PrEP programme will be rolled out in Ireland before the end of 2019 in an effort to reduce the number of HIV diagnoses in the country.
The “centralisation” of servers for the maternal and newborn clinical management system...
The ‘understanding and managing adult ADHD programme’ (UMAAP) began the first round..
The ICGP is examining alternative pathways for entry into general practice training as part of efforts...
In December, the HSE released part of an external review into the case of 'Brandon', a...
The evidence on doctor burnout “should scare us and concern us”, the Director of the RCSI...
A review of public health governance structures and addressing “longstanding” IT infrastructure...
Leave a Reply
You must be logged in to post a comment.